NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.500

+11.1%

12:17 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: xcentral1 who wrote (1828)	3/6/2010 11:44:18 AM
From: donpat	Read Replies (1) of 12871

Re--This shelf registration will give us substantial flexibility for financing our planned future work.-- What does that mean --substantial flexibility--? What are the various options now available?? Say we need $5 million for FDA trials of our HIVCide - where will that money come from? Selling enough shares to raise $5 million? Sell to whom? The general public? Financiers? Who? Novartis? Alcon? Other possible affiliates? Those with a major interest in HIV like Merck, Pfizer, Glaxo - note: medicalnewstoday.com . The flexibilities are considerable! I'm impressed. But then, again, I am easily impressed - mostly by things of immense potential.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next